Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12
✍ Scribed by Mazzolini, G; Narvaiza, I; Pérez-Diez, A; Rodriguez-Calvillo, M; Qian, C; Sangro, B; Ruiz, J; Prieto, J; Melero, I
- Book ID
- 110038871
- Publisher
- Nature Publishing Group
- Year
- 2001
- Tongue
- English
- Weight
- 424 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0969-7128
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background IL-12 is a potent antitumor cytokine for cancer gene therapy. Previously, we demonstrated that single systemic administration of naked DNA (encoding IL-12) could serve as a good model for in vivo evaluation of the antitumor effect of a candidate gene (unpublished data). In the present stu
## Abstract ## Background The present study aimed to evaluate the antitumor effectiveness of systemic __interleukin (IL)‐12__ gene therapy in murine sarcoma models, and to evaluate its interaction with the irradiation of tumors and metastases. To avoid toxic side‐effects of __IL‐12__ gene therapy,